SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

NCT05752461 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of Venous Thromboembolism After Knee Arthroplasty

Interventions

DRUG: SHR-2004 injection
DRUG: SHR-2004 injection
DRUG: SHR-2004 injection
DRUG: Enoxaparin sodium injection

Sponsor

Beijing Suncadia Pharmaceuticals Co., Ltd